Pfizer Will Seek COVID-19 Vaccine Approval for Kids Aged 2 to 11 This Fall

This week, the company gained emergency use authorization to start vaccinating kids aged 12 to 15.
save article
profile picture of Nehal Aggarwal
Published May 11, 2021
Toddler with her mom at the doctor's office.
Image: The Good Brigade / Getty Images

Kids aged 2 to 11 years old may be eligible for a COVID-19 vaccine this fall.

Last week, Albert Bourla, D.V.M., Ph.D., the chairman and CEO of Pfizer announced he planned to seek emergency use authorization (EUA) from the FDA in September to give the vaccine to kids aged 2 to 11. The company plans to seek EUA for kids aged 6 months to 2 years during the fourth quarter of 2021. This week, the FDA also granted Pfizer emergency use authorization of its COVID-19 vaccine in kids aged 12 to 15.

Earlier this year, Pfizer stated it would include pregnant women in vaccine trials, and the company aims to have clinical trial data on how safe the vaccine is for pregnant women in early August.

Pfizer is taking big steps to bring its vaccine to all. Last week Dr. Bourla also announced the company plans to apply for full approval of its vaccine for use in people aged 16 to 85 this month.

According to The New York Times, full approval could make it easier for schools, companies and government agencies to require the vaccine. Plus, it may also help ease a lot of vaccine hesitancy that persists as the rates of vaccination slow down in America.

Please note: The Bump and the materials and information it contains are not intended to, and do not constitute, medical or other health advice or diagnosis and should not be used as such. You should always consult with a qualified physician or health professional about your specific circumstances.

save article

Next on Your Reading List

Article removed.
Name added. View Your List